Hindustan Active Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -100.00%
(FY 2022)
- Ebitda -100.00%
(FY 2022)
- Net Worth -5.13%
(FY 2022)
- Total Assets %
(FY 2022)
About Hindustan Active Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhavna Doshi, Rajesh Doshi, Kunjal Dedhia, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110MH2020PLC348935
- Company No.
348935
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hindustan Active Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavna Doshi  | Director | 28-Oct-2020 | Current |
| Rajesh Doshi | Director | 28-Oct-2020 | Current |
| Kunjal Dedhia | Director | 28-Oct-2020 | Current |
| Vijay Gadhia | Director | 28-Oct-2020 | Current |
Financial Performance of Hindustan Active Pharmaceuticals.
Hindustan Active Pharmaceuticals Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 100% decrease in profit. The company's net worth dipped by a decrease of 5.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hindustan Active Pharmaceuticals?
In 2022, Hindustan Active Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hindustan Laboratories LimitedActive 7 years 6 monthsRajesh Doshi, Kunjal Dedhia and 1 more are mutual person
Hindustan Realty LimitedActive 11 years 6 monthsBhavna Doshi, Rajesh Doshi and 2 more are mutual person
- Hindustan Formulations LimitedActive 5 months 23 days
Rajesh Doshi, Kunjal Dedhia and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hindustan Active Pharmaceuticals?
Hindustan Active Pharmaceuticals has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hindustan Active Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindustan Active Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
